Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL103285

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(Br)c3)[nH]n2)cc1

Basic Information

ChEMBL ID CHEMBL103285
Phase Preclinical
Structure Type MOL
InChI Key UVWRLACHEXXROY-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

393.3
MW (Da)
3.23
ALogP
4
HBA
3
HBD
100.9
PSA (Ų)
0.63
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C15H13BrN4O2S
MW 393.27
Aromatic Rings 3
Heavy Atoms 23
NP-Likeness -1.75

Activity Summary

IC50 1 meas. best 7.63

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Cyclin-dependent kinase 2
CHEMBL301
IC50 7.63 7.63 23.4 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Cyclin-dependent kinase 2 IC50 = 23.4 nM 7.63 In vitro inhibition of Cyclin-dependent kinase 2 was determined. 12941317

Literature References

PubMed DOI Target Context # Activities
12941317 10.1016/s0960-894x(03)00630-9 Cyclin-dependent kinase 1 1
12941317 10.1016/s0960-894x(03)00630-9 Cyclin-dependent kinase 2 1

Data from ChEMBL 36 via Core Engine